{"id":"https://openalex.org/W7224823136","doi":"https://doi.org/10.1158/1535-7163.mct-25-0332","title":"GD2 Induction by Combination Chromatin-Directed Inhibitors Enhances Targeting of Ewing Sarcoma and Osteosarcoma by CAR T Cells","display_name":"GD2 Induction by Combination Chromatin-Directed Inhibitors Enhances Targeting of Ewing Sarcoma and Osteosarcoma by CAR T Cells","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224823136","doi":"https://doi.org/10.1158/1535-7163.mct-25-0332","pmid":"https://pubmed.ncbi.nlm.nih.gov/42962070"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-25-0332","doi":"https://doi.org/10.1158/1535-7163.mct-25-0332","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-25-0332","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1158/1535-7163.mct-25-0332","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034948591","display_name":"Justin R. Sperlazza","orcid":"https://orcid.org/0000-0002-4440-5566","observed_orcids":["https://orcid.org/0000-0002-4440-5566"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin R. Sperlazza","raw_affiliation_strings":["University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-4440-5566","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034444176","display_name":"Kevin P. Field","orcid":"https://orcid.org/0000-0003-3787-3203","observed_orcids":["https://orcid.org/0000-0003-3787-3203"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin C. Field","raw_affiliation_strings":["University of North Carolina at Chapel Hill 2 Curriculum in Genetics and Molecular Biology, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 3 MD-PhD Program, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0003-3787-3203","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 2 Curriculum in Genetics and Molecular Biology, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 3 MD-PhD Program, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085868101","display_name":"Caitlyn McComb","orcid":"https://orcid.org/0009-0005-5131-1786","observed_orcids":["https://orcid.org/0009-0005-5131-1786"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlyn McComb","raw_affiliation_strings":["5Department of Pediatrics, School of Medicine, Duke University, Durham, North Carolina","University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0009-0005-5131-1786","affiliations":[{"raw_affiliation_string":"5Department of Pediatrics, School of Medicine, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021996903","display_name":"Elisa Landoni","orcid":"https://orcid.org/0009-0005-8450-6256","observed_orcids":["https://orcid.org/0009-0005-8450-6256"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisa Landoni","raw_affiliation_strings":["University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0009-0005-8450-6256","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085866711","display_name":"Sara K. Peterson","orcid":"https://orcid.org/0009-0002-9858-2477","observed_orcids":["https://orcid.org/0009-0002-9858-2477"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara K. Peterson","raw_affiliation_strings":["University of North Carolina at Chapel Hill 6 Curriculum in Bioinformatics and Computational Biology, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0009-0002-9858-2477","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 6 Curriculum in Bioinformatics and Computational Biology, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160226764","display_name":"Anna Jin","orcid":"https://orcid.org/0009-0002-0546-3197","observed_orcids":["https://orcid.org/0009-0002-0546-3197"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Jin","raw_affiliation_strings":["University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0009-0002-0546-3197","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050568621","display_name":"Austin J. Hepperla","orcid":"https://orcid.org/0000-0002-0107-2001","observed_orcids":["https://orcid.org/0000-0002-0107-2001"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Austin J. Hepperla","raw_affiliation_strings":["University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 7 Department of Genetics, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 8 Bioinformatics and Analytics Research Collaborative, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 9 Carolina Institute for Developmental Disabilities, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-0107-2001","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 7 Department of Genetics, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 8 Bioinformatics and Analytics Research Collaborative, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 9 Carolina Institute for Developmental Disabilities, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160197232","display_name":"Rachel L. Chambers","orcid":"https://orcid.org/0009-0005-7222-9933","observed_orcids":["https://orcid.org/0009-0005-7222-9933"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel L. Chambers","raw_affiliation_strings":["University of North Carolina at Chapel Hill 10 UNC Eshelman School of Pharmacy, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0009-0005-7222-9933","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 10 UNC Eshelman School of Pharmacy, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085654922","display_name":"William C. Zamboni","orcid":"https://orcid.org/0000-0002-8319-4482","observed_orcids":["https://orcid.org/0000-0002-8319-4482"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William C. Zamboni","raw_affiliation_strings":["University of North Carolina at Chapel Hill 10 UNC Eshelman School of Pharmacy, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-8319-4482","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 10 UNC Eshelman School of Pharmacy, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065544223","display_name":"Barbara Savoldo","orcid":"https://orcid.org/0000-0002-7571-3887","observed_orcids":["https://orcid.org/0000-0002-7571-3887"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Savoldo","raw_affiliation_strings":["University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-7571-3887","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041976491","display_name":"Ian J. Davis","orcid":"https://orcid.org/0000-0002-1552-0960","observed_orcids":["https://orcid.org/0000-0002-1552-0960"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ian J. Davis","raw_affiliation_strings":["University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","University of North Carolina at Chapel Hill 7 Department of Genetics, School of Medicine, , Chapel Hill, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-1552-0960","affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill 1 Department of Pediatrics, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 4 Lineberger Comprehensive Cancer Center, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill 7 Department of Genetics, School of Medicine, , Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5041976491"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83564533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"OF1","last_page":"OF16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gd2","display_name":"GD2","score":0.9449999928474426},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":1.0},{"id":"https://openalex.org/keywords/tazemetostat","display_name":"tazemetostat","score":0.8880000114440918},{"id":"https://openalex.org/keywords/entinostat","display_name":"entinostat","score":0.8830000162124634},{"id":"https://openalex.org/keywords/ezh2-inhibition","display_name":"EZH2 inhibition","score":0.7239999771118164},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibition","display_name":"histone deacetylase inhibition","score":0.7200000286102295},{"id":"https://openalex.org/keywords/dot1l-inhibition","display_name":"DOT1L inhibition","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-antigen-expression","display_name":"tumor antigen expression","score":0.7400000095367432},{"id":"https://openalex.org/keywords/adoptive-cellular-therapy","display_name":"adoptive cellular therapy","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7372000217437744},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6416000127792358},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.576200008392334},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.527400016784668},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44780001044273376},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4332999885082245},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3955000042915344},{"id":"https://openalex.org/C2777586341","wikidata":"https://www.wikidata.org/wiki/Q1138580","display_name":"Ewing's sarcoma","level":3,"score":0.35339999198913574},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.33309999108314514},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.3294999897480011},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.32829999923706055},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3273000121116638},{"id":"https://openalex.org/C2776910622","wikidata":"https://www.wikidata.org/wiki/Q2619315","display_name":"Synovial sarcoma","level":3,"score":0.31369999051094055},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.31119999289512634},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.30730000138282776},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.29910001158714294},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.2883000075817108},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.28360000252723694},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.2775000035762787},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.2736999988555908},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2628999948501587},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.25040000677108765}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-25-0332","doi":"https://doi.org/10.1158/1535-7163.mct-25-0332","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-25-0332","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:42962070","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42962070","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-25-0332","doi":"https://doi.org/10.1158/1535-7163.mct-25-0332","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-25-0332","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306536","display_name":"V Foundation for Cancer Research","ror":"https://ror.org/00kbbk236"},{"id":"https://openalex.org/F4320306589","display_name":"Alex's Lemonade Stand Foundation for Childhood Cancer","ror":"https://ror.org/038ja4880"},{"id":"https://openalex.org/F4320308571","display_name":"North Carolina Biotechnology Center","ror":"https://ror.org/03hj4jr80"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7170937615","https://openalex.org/W7214020178","https://openalex.org/W7165488946","https://openalex.org/W2917149656","https://openalex.org/W7148730011","https://openalex.org/W6887839802","https://openalex.org/W4405516812","https://openalex.org/W2937064585","https://openalex.org/W2036887801","https://openalex.org/W2885241369"],"abstract_inverted_index":{"Adoptive":[0],"cellular":[1],"therapies":[2],"depend":[3],"on":[4,11],"the":[5,41,59,114,119,145,173],"adequate":[6],"expression":[7,129,156],"of":[8,18,43,96,105,147,175],"target":[9,17],"antigens":[10],"tumors.":[12],"The":[13],"disialoganglioside":[14],"GD2,":[15],"a":[16,88,94],"chimeric":[19],"antigen":[20],"receptor":[21],"(CAR)":[22],"T":[23,26,56,165],"cells":[24],"(GD2.CAR":[25],"cells)":[27],"and":[28,37,51,68,109,118,149,157,186],"monoclonal":[29],"antibodies,":[30],"is":[31],"variably":[32],"expressed":[33],"in":[34,66,69,87,132,152],"Ewing":[35,184],"sarcoma":[36,185],"osteosarcoma.":[38,187],"We":[39,92],"investigated":[40],"ability":[42],"chromatin-directed":[44,97,176],"small":[45,98],"molecules":[46,99],"to":[47,54,76,83,100,159],"enhance":[48],"tumor":[49,79,85,107,127,154,161],"GD2":[50,64,80,108,128,155],"sensitize":[52],"tumors":[53],"GD2.CAR":[55,164],"cells.":[57,166],"Although":[58],"EZH2":[60],"inhibitor":[61,116,121],"tazemetostat":[62,72,131,148],"increased":[63],"levels":[65,81],"culture":[67,133],"xenografted":[70],"mice,":[71],"treatment":[73],"was":[74],"unable":[75],"maintain":[77],"sufficient":[78],"necessary":[82],"enable":[84],"control":[86,162],"metastatic":[89],"xenograft":[90,143],"model.":[91],"performed":[93],"screen":[95],"identify":[101],"additional":[102],"compounds":[103,124],"capable":[104],"regulating":[106],"identified":[110],"multiple":[111,142],"compounds,":[112],"including":[113],"HDAC":[115],"entinostat":[117,150],"DOT1L":[120],"pinometostat.":[122],"Both":[123],"greatly":[125],"enhanced":[126,153],"by":[130,163],"but":[134],"did":[135],"not":[136],"limit":[137],"CAR":[138,180],"T-cell":[139,181],"activity.":[140],"In":[141],"models,":[144],"combination":[146],"resulted":[151],"led":[158],"long-term":[160],"These":[167],"data":[168],"offer":[169],"preclinical":[170],"support":[171],"for":[172,183],"incorporation":[174],"inhibitors":[177],"into":[178],"ongoing":[179],"trials":[182]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}